Another important difference lies in the interpretation of risk and benefit
No longer taking semaglutide means the effects of decreasing your appetite gradually wear off
Avoid High-Risk NSAIDs : Certain NSAIDs, like aspirin or ibuprofen, may pose a higher risk of stomach issues
Wegovy is the brand name for semaglutide 2.4 mg , a medication developed by Novo Nordisk for chronic weight management is available in Delhi, Kolkata, Surat, Jaipur, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, Noida, Kanpur, Lucknow, Dehradun, Shimla, Ahmedabad, Jodhpur, Mumbai, Jaipur, Aurangabad, Pune, Bangalore, Hyderabad, Chennai, Visakhapatnam, Coimbatore, Andhra Pradesh, Karnataka, Kerala, Lakshadweep, Puducherry, Tamil Nadu, Telangana, India